IWMF Seeks New Young Investigators
Understanding Your Blood and Bone Marrow Test Results
The IWMF is excited to announce that Peter DeNardis will serve as the new Chair of the Board of Trustees
The IWMF is excited to announce the addition of two new members to the Board of Trustees
Dr. Steven Treon's Legacy Project Focuses on MYD88 Signaling
WM Specialists Added from Argentina, Greece, Israel, Poland and South Africa
IgM MGUS & Smoldering WM: How Understanding Precursors Can Help in Finding a Cure
Read Sharon's story HERE.
The authors analyzed 160 young patients diagnosed with WM, median age of 49 years (range 23-55), from 18 treatment centers in Italy. Early diagnosis, absence of high‐risk features in symptomatic patients, and high efficacy of modern treatments are the main determinants of the excellent outcomes...
Important Login Information